What is Hansoh Pharma?
Hansoh Pharmaceutical Group Company Limited is a leading Chinese biopharmaceutical company that specializes in the research, development, and manufacture of innovative drugs and generic medicines. The company focuses on critical therapeutic areas including oncology, metabolic diseases, anti-infectives, and central nervous system disorders. It maintains a large portfolio of approved products and a robust pipeline of late-stage clinical candidates. As one of China's most significant pharmaceutical players, Hansoh is recognized for its high investment in R&D and its strategic partnerships with global pharma firms, aiming to translate advanced laboratory science into commercial products that address the evolving healthcare needs of the Chinese market and international patients, focusing particularly on unmet therapeutic demands in oncology and beyond.
Related FAQs
TORM plc is a leading global shipping enterprise specializing in the ownership and operation of refined oil tankers, providing vital maritime transport solutions for energy markets worldwide.
Hansoh Pharmaceutical Group Company Limited is a completely legitimate, publicly traded biopharmaceutical enterprise listed on the Stock Exchange of Hong Kong under stock code 3692.
Sun Pharma is an entirely legitimate, highly regulated, publicly traded multinational pharmaceutical corporate heavyweight listed on major stock exchanges including the Bombay Stock Exchange and the National Stock Exchange of India.
The global healthcare and biopharmaceutical sector is anchored by massive multinational corporations driving medical innovations and blockbuster drug sales.
Pharmaceutical products encompass a vast array of chemical compounds, biological formulations, and therapeutic substances designed to prevent, diagnose, alleviate, or cure medical conditions.
Hansoh Pharmaceutical Group Company Limited is a leading biopharmaceutical enterprise focusing on the discovery, development, and commercialization of innovative medicines targeting major human diseases.
The global biopharmaceutical industry features elite mega-cap corporations that command immense equity market valuations driven by blockbuster drug portfolios, advanced biologic pipelines, and high-demand therapeutic treatments.
The primary principal place of business and corporate office for Hansoh Pharmaceutical Group Company Limited in Hong Kong is located at Room 1928, 19th Floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.